Live attenuated vaccines are vaccines made from killed pathogens.
This report contains market size and forecasts of Live Attenuated Vaccines for Pets in global, including the following market information:
Global Live Attenuated Vaccines for Pets Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Live Attenuated Vaccines for Pets Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Live Attenuated Vaccines for Pets companies in 2022 (%)
The global Live Attenuated Vaccines for Pets market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Virus Attenuated Vaccine Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Live Attenuated Vaccines for Pets include Bayer Healthcare, Vetoquinol S.A, Boehringer Ingelheim, Ceva, Eli Lilly, Heska, Merck Animal Health, Merial (Sanofi) and Virbac and etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Live Attenuated Vaccines for Pets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Live Attenuated Vaccines for Pets Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Live Attenuated Vaccines for Pets Market Segment Percentages, by Type, 2022 (%)
Virus Attenuated Vaccine
Bacterial Attenuated Vaccine
Global Live Attenuated Vaccines for Pets Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Live Attenuated Vaccines for Pets Market Segment Percentages, by Application, 2022 (%)
Dog
Cat
Dird
Others
Global Live Attenuated Vaccines for Pets Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Live Attenuated Vaccines for Pets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Live Attenuated Vaccines for Pets revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Live Attenuated Vaccines for Pets revenues share in global market, 2022 (%)
Key companies Live Attenuated Vaccines for Pets sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Live Attenuated Vaccines for Pets sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Live Attenuated Vaccines for Pets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Live Attenuated Vaccines for Pets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Live Attenuated Vaccines for Pets Overall Market Size
2.1 Global Live Attenuated Vaccines for Pets Market Size: 2022 VS 2030
2.2 Global Live Attenuated Vaccines for Pets Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Live Attenuated Vaccines for Pets Sales: 2018-2030
3 Company Landscape
3.1 Top Live Attenuated Vaccines for Pets Players in Global Market
3.2 Top Global Live Attenuated Vaccines for Pets Companies Ranked by Revenue
3.3 Global Live Attenuated Vaccines for Pets Revenue by Companies
3.4 Global Live Attenuated Vaccines for Pets Sales by Companies
3.5 Global Live Attenuated Vaccines for Pets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Live Attenuated Vaccines for Pets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Live Attenuated Vaccines for Pets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Live Attenuated Vaccines for Pets Players in Global Market
3.8.1 List of Global Tier 1 Live Attenuated Vaccines for Pets Companies
3.8.2 List of Global Tier 2 and Tier 3 Live Attenuated Vaccines for Pets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Live Attenuated Vaccines for Pets Market Size Markets, 2022 & 2030
4.1.2 Virus Attenuated Vaccine
4.1.3 Bacterial Attenuated Vaccine
4.2 By Type - Global Live Attenuated Vaccines for Pets Revenue & Forecasts
4.2.1 By Type - Global Live Attenuated Vaccines for Pets Revenue, 2018-2023
4.2.2 By Type - Global Live Attenuated Vaccines for Pets Revenue, 2023-2030
4.2.3 By Type - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
4.3 By Type - Global Live Attenuated Vaccines for Pets Sales & Forecasts
4.3.1 By Type - Global Live Attenuated Vaccines for Pets Sales, 2018-2023
4.3.2 By Type - Global Live Attenuated Vaccines for Pets Sales, 2023-2030
4.3.3 By Type - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
4.4 By Type - Global Live Attenuated Vaccines for Pets Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Live Attenuated Vaccines for Pets Market Size, 2022 & 2030
5.1.2 Dog
5.1.3 Cat
5.1.4 Dird
5.1.5 Others
5.2 By Application - Global Live Attenuated Vaccines for Pets Revenue & Forecasts
5.2.1 By Application - Global Live Attenuated Vaccines for Pets Revenue, 2018-2023
5.2.2 By Application - Global Live Attenuated Vaccines for Pets Revenue, 2023-2030
5.2.3 By Application - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
5.3 By Application - Global Live Attenuated Vaccines for Pets Sales & Forecasts
5.3.1 By Application - Global Live Attenuated Vaccines for Pets Sales, 2018-2023
5.3.2 By Application - Global Live Attenuated Vaccines for Pets Sales, 2023-2030
5.3.3 By Application - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
5.4 By Application - Global Live Attenuated Vaccines for Pets Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Live Attenuated Vaccines for Pets Market Size, 2022 & 2030
6.2 By Region - Global Live Attenuated Vaccines for Pets Revenue & Forecasts
6.2.1 By Region - Global Live Attenuated Vaccines for Pets Revenue, 2018-2023
6.2.2 By Region - Global Live Attenuated Vaccines for Pets Revenue, 2023-2030
6.2.3 By Region - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
6.3 By Region - Global Live Attenuated Vaccines for Pets Sales & Forecasts
6.3.1 By Region - Global Live Attenuated Vaccines for Pets Sales, 2018-2023
6.3.2 By Region - Global Live Attenuated Vaccines for Pets Sales, 2023-2030
6.3.3 By Region - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Live Attenuated Vaccines for Pets Revenue, 2018-2030
6.4.2 By Country - North America Live Attenuated Vaccines for Pets Sales, 2018-2030
6.4.3 US Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.4.4 Canada Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.4.5 Mexico Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Live Attenuated Vaccines for Pets Revenue, 2018-2030
6.5.2 By Country - Europe Live Attenuated Vaccines for Pets Sales, 2018-2030
6.5.3 Germany Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.5.4 France Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.5.5 U.K. Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.5.6 Italy Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.5.7 Russia Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.5.8 Nordic Countries Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.5.9 Benelux Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Live Attenuated Vaccines for Pets Revenue, 2018-2030
6.6.2 By Region - Asia Live Attenuated Vaccines for Pets Sales, 2018-2030
6.6.3 China Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.6.4 Japan Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.6.5 South Korea Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.6.6 Southeast Asia Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.6.7 India Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Live Attenuated Vaccines for Pets Revenue, 2018-2030
6.7.2 By Country - South America Live Attenuated Vaccines for Pets Sales, 2018-2030
6.7.3 Brazil Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.7.4 Argentina Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Live Attenuated Vaccines for Pets Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Live Attenuated Vaccines for Pets Sales, 2018-2030
6.8.3 Turkey Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.8.4 Israel Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.8.5 Saudi Arabia Live Attenuated Vaccines for Pets Market Size, 2018-2030
6.8.6 UAE Live Attenuated Vaccines for Pets Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Bayer Healthcare
7.1.1 Bayer Healthcare Corporate Summary
7.1.2 Bayer Healthcare Business Overview
7.1.3 Bayer Healthcare Live Attenuated Vaccines for Pets Major Product Offerings
7.1.4 Bayer Healthcare Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.1.5 Bayer Healthcare Key News
7.2 Vetoquinol S.A
7.2.1 Vetoquinol S.A Corporate Summary
7.2.2 Vetoquinol S.A Business Overview
7.2.3 Vetoquinol S.A Live Attenuated Vaccines for Pets Major Product Offerings
7.2.4 Vetoquinol S.A Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.2.5 Vetoquinol S.A Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Live Attenuated Vaccines for Pets Major Product Offerings
7.3.4 Boehringer Ingelheim Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim Key News
7.4 Ceva
7.4.1 Ceva Corporate Summary
7.4.2 Ceva Business Overview
7.4.3 Ceva Live Attenuated Vaccines for Pets Major Product Offerings
7.4.4 Ceva Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.4.5 Ceva Key News
7.5 Eli Lilly
7.5.1 Eli Lilly Corporate Summary
7.5.2 Eli Lilly Business Overview
7.5.3 Eli Lilly Live Attenuated Vaccines for Pets Major Product Offerings
7.5.4 Eli Lilly Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly Key News
7.6 Heska
7.6.1 Heska Corporate Summary
7.6.2 Heska Business Overview
7.6.3 Heska Live Attenuated Vaccines for Pets Major Product Offerings
7.6.4 Heska Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.6.5 Heska Key News
7.7 Merck Animal Health
7.7.1 Merck Animal Health Corporate Summary
7.7.2 Merck Animal Health Business Overview
7.7.3 Merck Animal Health Live Attenuated Vaccines for Pets Major Product Offerings
7.7.4 Merck Animal Health Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.7.5 Merck Animal Health Key News
7.8 Merial (Sanofi)
7.8.1 Merial (Sanofi) Corporate Summary
7.8.2 Merial (Sanofi) Business Overview
7.8.3 Merial (Sanofi) Live Attenuated Vaccines for Pets Major Product Offerings
7.8.4 Merial (Sanofi) Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.8.5 Merial (Sanofi) Key News
7.9 Virbac
7.9.1 Virbac Corporate Summary
7.9.2 Virbac Business Overview
7.9.3 Virbac Live Attenuated Vaccines for Pets Major Product Offerings
7.9.4 Virbac Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.9.5 Virbac Key News
7.10 Zoetis (Pfizer)
7.10.1 Zoetis (Pfizer) Corporate Summary
7.10.2 Zoetis (Pfizer) Business Overview
7.10.3 Zoetis (Pfizer) Live Attenuated Vaccines for Pets Major Product Offerings
7.10.4 Zoetis (Pfizer) Live Attenuated Vaccines for Pets Sales and Revenue in Global (2018-2023)
7.10.5 Zoetis (Pfizer) Key News
8 Global Live Attenuated Vaccines for Pets Production Capacity, Analysis
8.1 Global Live Attenuated Vaccines for Pets Production Capacity, 2018-2030
8.2 Live Attenuated Vaccines for Pets Production Capacity of Key Manufacturers in Global Market
8.3 Global Live Attenuated Vaccines for Pets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Live Attenuated Vaccines for Pets Supply Chain Analysis
10.1 Live Attenuated Vaccines for Pets Industry Value Chain
10.2 Live Attenuated Vaccines for Pets Upstream Market
10.3 Live Attenuated Vaccines for Pets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Live Attenuated Vaccines for Pets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Live Attenuated Vaccines for Pets in Global Market
Table 2. Top Live Attenuated Vaccines for Pets Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Live Attenuated Vaccines for Pets Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Live Attenuated Vaccines for Pets Revenue Share by Companies, 2018-2023
Table 5. Global Live Attenuated Vaccines for Pets Sales by Companies, (K Units), 2018-2023
Table 6. Global Live Attenuated Vaccines for Pets Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Live Attenuated Vaccines for Pets Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Live Attenuated Vaccines for Pets Product Type
Table 9. List of Global Tier 1 Live Attenuated Vaccines for Pets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Live Attenuated Vaccines for Pets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2023-2030
Table 14. By Type - Global Live Attenuated Vaccines for Pets Sales (K Units), 2018-2023
Table 15. By Type - Global Live Attenuated Vaccines for Pets Sales (K Units), 2023-2030
Table 16. By Application ? Global Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2023-2030
Table 19. By Application - Global Live Attenuated Vaccines for Pets Sales (K Units), 2018-2023
Table 20. By Application - Global Live Attenuated Vaccines for Pets Sales (K Units), 2023-2030
Table 21. By Region ? Global Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Live Attenuated Vaccines for Pets Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global Live Attenuated Vaccines for Pets Sales (K Units), 2018-2023
Table 25. By Region - Global Live Attenuated Vaccines for Pets Sales (K Units), 2023-2030
Table 26. By Country - North America Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America Live Attenuated Vaccines for Pets Sales, (K Units), 2018-2023
Table 29. By Country - North America Live Attenuated Vaccines for Pets Sales, (K Units), 2023-2030
Table 30. By Country - Europe Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe Live Attenuated Vaccines for Pets Sales, (K Units), 2018-2023
Table 33. By Country - Europe Live Attenuated Vaccines for Pets Sales, (K Units), 2023-2030
Table 34. By Region - Asia Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia Live Attenuated Vaccines for Pets Sales, (K Units), 2018-2023
Table 37. By Region - Asia Live Attenuated Vaccines for Pets Sales, (K Units), 2023-2030
Table 38. By Country - South America Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America Live Attenuated Vaccines for Pets Sales, (K Units), 2018-2023
Table 41. By Country - South America Live Attenuated Vaccines for Pets Sales, (K Units), 2023-2030
Table 42. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Sales, (K Units), 2023-2030
Table 46. Bayer Healthcare Corporate Summary
Table 47. Bayer Healthcare Live Attenuated Vaccines for Pets Product Offerings
Table 48. Bayer Healthcare Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Vetoquinol S.A Corporate Summary
Table 50. Vetoquinol S.A Live Attenuated Vaccines for Pets Product Offerings
Table 51. Vetoquinol S.A Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 52. Boehringer Ingelheim Corporate Summary
Table 53. Boehringer Ingelheim Live Attenuated Vaccines for Pets Product Offerings
Table 54. Boehringer Ingelheim Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 55. Ceva Corporate Summary
Table 56. Ceva Live Attenuated Vaccines for Pets Product Offerings
Table 57. Ceva Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 58. Eli Lilly Corporate Summary
Table 59. Eli Lilly Live Attenuated Vaccines for Pets Product Offerings
Table 60. Eli Lilly Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Heska Corporate Summary
Table 62. Heska Live Attenuated Vaccines for Pets Product Offerings
Table 63. Heska Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 64. Merck Animal Health Corporate Summary
Table 65. Merck Animal Health Live Attenuated Vaccines for Pets Product Offerings
Table 66. Merck Animal Health Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 67. Merial (Sanofi) Corporate Summary
Table 68. Merial (Sanofi) Live Attenuated Vaccines for Pets Product Offerings
Table 69. Merial (Sanofi) Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 70. Virbac Corporate Summary
Table 71. Virbac Live Attenuated Vaccines for Pets Product Offerings
Table 72. Virbac Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Zoetis (Pfizer) Corporate Summary
Table 74. Zoetis (Pfizer) Live Attenuated Vaccines for Pets Product Offerings
Table 75. Zoetis (Pfizer) Live Attenuated Vaccines for Pets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 76. Live Attenuated Vaccines for Pets Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 77. Global Live Attenuated Vaccines for Pets Capacity Market Share of Key Manufacturers, 2021-2023
Table 78. Global Live Attenuated Vaccines for Pets Production by Region, 2018-2023 (K Units)
Table 79. Global Live Attenuated Vaccines for Pets Production by Region, 2023-2030 (K Units)
Table 80. Live Attenuated Vaccines for Pets Market Opportunities & Trends in Global Market
Table 81. Live Attenuated Vaccines for Pets Market Drivers in Global Market
Table 82. Live Attenuated Vaccines for Pets Market Restraints in Global Market
Table 83. Live Attenuated Vaccines for Pets Raw Materials
Table 84. Live Attenuated Vaccines for Pets Raw Materials Suppliers in Global Market
Table 85. Typical Live Attenuated Vaccines for Pets Downstream
Table 86. Live Attenuated Vaccines for Pets Downstream Clients in Global Market
Table 87. Live Attenuated Vaccines for Pets Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Live Attenuated Vaccines for Pets Segment by Type
Figure 2. Live Attenuated Vaccines for Pets Segment by Application
Figure 3. Global Live Attenuated Vaccines for Pets Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Live Attenuated Vaccines for Pets Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Live Attenuated Vaccines for Pets Revenue, 2018-2030 (US$, Mn)
Figure 7. Live Attenuated Vaccines for Pets Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Live Attenuated Vaccines for Pets Revenue in 2022
Figure 9. By Type - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
Figure 10. By Type - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
Figure 11. By Type - Global Live Attenuated Vaccines for Pets Price (US$/Unit), 2018-2030
Figure 12. By Application - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
Figure 13. By Application - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
Figure 14. By Application - Global Live Attenuated Vaccines for Pets Price (US$/Unit), 2018-2030
Figure 15. By Region - Global Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
Figure 16. By Region - Global Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
Figure 17. By Country - North America Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
Figure 18. By Country - North America Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
Figure 19. US Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 20. Canada Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
Figure 23. By Country - Europe Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
Figure 24. Germany Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 25. France Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 27. Italy Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 28. Russia Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
Figure 32. By Region - Asia Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
Figure 33. China Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 34. Japan Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 37. India Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
Figure 39. By Country - South America Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
Figure 40. Brazil Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa Live Attenuated Vaccines for Pets Sales Market Share, 2018-2030
Figure 44. Turkey Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 45. Israel Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 47. UAE Live Attenuated Vaccines for Pets Revenue, (US$, Mn), 2018-2030
Figure 48. Global Live Attenuated Vaccines for Pets Production Capacity (K Units), 2018-2030
Figure 49. The Percentage of Production Live Attenuated Vaccines for Pets by Region, 2022 VS 2030
Figure 50. Live Attenuated Vaccines for Pets Industry Value Chain
Figure 51. Marketing Channels
